Integer Holdings Corporation (ITGR)

NYSE · Medical Devices

125.39
+0.14 (+0.11%)
Updated Sep 1, 8:21 PM ET
AI Rating
Strong Buy
Overall Score
78
Trend
100
Momentum
42
Risk
92

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 19, 2025 260 sessions Aug 31, 2026

AI Analysis

Integer Holdings Corporation is trading at $125.39, up 0.11% on the session. The 50 day average sits at $107.52 and the 200 day at $89.41, which puts the stock in a uptrend. RSI is at 80.4, which reads as overbought, and MACD is bearish crossover. Volume is below average.

The nearest support is around $124.84 with resistance near $125.44, so that band frames the current range. Average daily movement is roughly $1.33, or about 1.1% of the share price, which is what any stop placement has to allow for. The overall health score of 78 out of 100 combines a trend score of 100, momentum of 42 and a risk score of 92.

Technical indicators

RSI (14)
80.4
overbought
MACD
5.065
bearish crossover
SMA 20
125.18
SMA 50
107.52
SMA 200
89.41
uptrend
ATR (14)
1.33
avg daily range
Support
124.84
Resistance
125.44
Volume vs 20d
0.33x
below average
Volatility
10.3%
annualised
1 month
+24.26%
3 months
+40.22%

About Integer Holdings Corporation

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.